Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) are widely used for their well-established benefit in reducing morbidity and mortality in patients with coronary artery disease and for renal protection in patients with diabetes mellitus. Here, ACE is linked to diabetes mellitus.